Address

Other Office
21 Waterway Avenue,
Suite 225
The Woodlands, TX 77380
United States

Open map


Recent investment activity

KANDO id: 30232

Corporate information

Registration country

Funding rounds

Top investment portfolio themes

Actual initial investment stage

Investment activity status
Active investor

Selected investments

Displaying 26 - 50 of 104
Profile Country Date Funding
Horizon Therapeutics Inc Biopharmaceutical company focused on the rapid development and commercialization of therapeutic treatments for mild-to-moderate pain management. N/A
ikaSystems Corp ikaSystems is a leading provider of integrated online software applications to the healthcare payer industry. N/A
Inhibitex Inc N/A
InSound Medical Inc Medical device company focused on the development and sale of next generation hearing aid solutions. Series D
IntegenX Inc Developing equipment for molecular diagnostics Series C
Iomai Corp Biopharmaceutical company focused on discovering and developing vaccines and immune system stimulants. Series C
Key Health Group Inc N/A
Key Health Medical Solutions Inc Healthcare receivables company working with patients with injuries who are uninsured. N/A
LifeCell Develops and markets biologic products for the repair or replacement of damaged or inadequate tissues. N/A
Light Sciences Oncology Inc Drug-device cancer therapy Series A
LipoSonix Inc A medical device company focused on the development of proprietary technology for noninvasive cosmetic surgery applications. N/A
MedAvante Provides centralized expert psychiatric rating and monitoring services to the pharmaceutical industry N/A
MediciNova Inc Focuses on acquiring and developing novel, small-molecule therapeutics for the US market. N/A
Medtronic ATS Medical Inc N/A
MicroMed Technology Developer of miniaturized heart pump technology. N/A
MicroPort Medical N/A
Millennium Pharmacy Systems Inc N/A
Molecular Partners AG N/A
Nellix Endovascular Inc N/A
Novacept Inc Commercializing innovative medical devices to improve the quality and cost-effectiveness of healthcare for women. N/A
Open Monoclonal Technology Inc Builds the first platform for generating human monoclonal antibodies using a transgenic rat. N/A
Oraya Therapeutics Inc Developing a radiation-based treatment for wet AMD Series C
Oraya Therapeutics Inc Developing a radiation-based treatment for wet AMD Series B
Oraya Therapeutics Inc Developing a radiation-based treatment for wet AMD Series A
Orthovita Inc Orthopedic surgical biomaterials company offering advanced bone regeneration and soft tissue healing technologies N/A

Current team

Past employees

Selected Products / Customers

Financials